Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Accountprinceon Jul 27, 2021 10:10am
177 Views
Post# 33609620

UP to 25% of Units Potentially Sold to Insiders

UP to 25% of Units Potentially Sold to InsidersThis morning's disclosure is certainly an eye opener.  So undefined insiders could participate in up to 25% of the offering.  Something should have been filed 21 days prior to their participation in the closing (July 6 for that filing?).  I haven't seen anything yet.

The disclosure also lists some exemptions they are relying upon to exempt them from rules governing treatment of non-insider shareholders.  Anyone familiar with these rules?

So we were at $0.53 per share.  A bought deal for units is done at $.425 per share and the share price is engineered to less than $0.40 per share and stays there until closing.  Insider provision to acquire 25% of the issue disclosed in press release concurrent with the closing announcement.

So if insider participation should have been disclosed say July 6 does the FMV get established that day or do you wait until they "negotiate" the bought deal with the underwriters on July 20 when the price is dropped?  Many questions and no answers. 

Looks like insiders will do anything to acquire more shares.  That - in a very perverse way - validates the value we all feel is there.


<< Previous
Bullboard Posts
Next >>